| Unnatural amino acids: production and biotechnological potential T Narancic, SA Almahboub, KE O’Connor World Journal of Microbiology and Biotechnology 35 (4), 67, 2019 | 117 | 2019 |
| SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamri, SA Almahboub, ... Scientific reports 10 (1), 16561, 2020 | 107 | 2020 |
| Evaluation of neutralizing antibodies against highly pathogenic coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular stomatitis … SA Almahboub, A Algaissi, MA Alfaleh, MZ ElAssouli, AM Hashem Frontiers in Microbiology 11, 2020, 2020 | 64 | 2020 |
| Early humoral response correlates with disease severity and outcomes in COVID-19 patients AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, ... Viruses 12 (12), 1390, 2020 | 58 | 2020 |
| Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 AA Degnah, SS Al-Amri, AM Hassan, AS Almasoud, M Mousa, ... Journal of infection and public health 13 (5), 697-703, 2020 | 32 | 2020 |
| Synthetic SARS-CoV-2 spike-based DNA vaccine elicits robust and long-lasting th1 humoral and cellular immunity in mice SS Alamri, KA Alluhaybi, RY Alhabbab, M Basabrain, A Algaissi, ... Frontiers in microbiology 12, 727455, 2021 | 27 | 2021 |
| Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity SA Almahboub, T Narancic, M Devocelle, ST Kenny, W Palmer-Brown, ... Applied microbiology and biotechnology 102, 789-799, 2018 | 15 | 2018 |
| Construction of VSVΔ51M oncolytic virus expressing human interleukin-12 RH Abdulal, JS Malki, E Ghazal, AA Alsaieedi, SA Almahboub, MY Khan, ... Frontiers in Molecular Biosciences 10, 1190669, 2023 | 7 | 2023 |
| SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients. Sci Rep 10: 16561 A Algaissi, MA Alfaleh, S Hala, TS Abujamel, SS Alamri, SA Almahboub, ... | 7 | 2020 |
| Single point mutations reveal amino acid residues important for Chromobacterium violaceum transaminase activity in the production of unnatural amino acids SA Almahboub, T Narancic, D Fayne, KE O’Connor Scientific Reports 8 (1), 17397, 2018 | 7 | 2018 |
| ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks MA Alfaleh, RM Alsulaiman, SA Almahboub, L Nezamuldeen, A Zawawi, ... Antibody Therapeutics 7 (1), 53-66, 2024 | 5 | 2024 |
| Early humoral response correlates with disease severity and outcomes in COVID-19 patients. Viruses 12: 1390 AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, ... | 2 | 2020 |
| Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future MB Bello, A Alsaadi, A Naeem, SA Almahboub, M Bosaeed, SS Aljedani Frontiers in Immunology 15, 1475886, 2025 | 1 | 2025 |
| Enhanced immunogenicity of a synthetic DNA vaccine expressing consensus SARS-CoV-2 Spike protein using needle-free immunization SS Alamri, KA Alluhaybi, RY Alhabbab, A Algaissi, S Almahboub, ... bioRxiv, 2021.02. 01.429219, 2021 | 1 | 2021 |
| Prevalence of MERS-CoV in Healthy Adults in Western Saudi Arabia, 2011-2016; a Retrospective, Cross-Sectional Seroepidemiological Study AA Degnah, SS Al-amri, AM Hassan, AS Almasoud, M Mousa, ... Cross-Sectional Seroepidemiological Study (June 24, 2019), 2019 | | 2019 |
